{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:30:12Z","timestamp":1792121412673,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.arcmed.2009.07.008","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T08:57:19Z","timestamp":1256201839000},"page":"514-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of a Quadrivalent HPV6\/11\/16\/18 Vaccine in Mexican Women: Public Health Implications for the Region"],"prefix":"10.1016","volume":"40","author":[{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Cruz-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Zamilpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Aranda-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Hern\u00e1ndez-Nevarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Viramontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Salgado-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Hern\u00e1ndez-Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 11","key":"10.1016\/j.arcmed.2009.07.008_bib1","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1016\/j.vaccine.2008.06.013","article-title":"Cervical cancer screening programs in Latin America and the Caribbean","volume":"26","author":"Murillo","year":"2008","journal-title":"Vaccine"},{"issue":"suppl 2","key":"10.1016\/j.arcmed.2009.07.008_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1590\/S0036-36342009000800011","article-title":"Diferencias regionales en la mortalidad por c\u00e1ncer de mama y c\u00e9rvix en M\u00e9xico entre 1979 y 2006","volume":"51","author":"Palacio-Mejia","year":"2009","journal-title":"Salud P\u00fablica M\u00e9x"},{"key":"10.1016\/j.arcmed.2009.07.008_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2008.01990.x","article-title":"Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined","volume":"116","author":"Herbert","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.arcmed.2009.07.008_bib4","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.arcmed.2009.07.008_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ije\/dyn096","article-title":"Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities","volume":"37","author":"Reyes-Ortiz","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.arcmed.2009.07.008_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6690666","article-title":"Trends in cancer of the cervix uteri in Sweden following cytological screening","volume":"81","author":"Bergstr\u00f6m","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.arcmed.2009.07.008_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cncr.24007","article-title":"Disparities in survival among women with invasive cervical cancer: a problem of access to care","volume":"115","author":"Brookfield","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2009.07.008_bib8","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"issue":"suppl 3","key":"10.1016\/j.arcmed.2009.07.008_bib9","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1590\/S0036-36342003000900005","article-title":"Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico","volume":"45","author":"Palacio-Mej\u00eda","year":"2003","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.arcmed.2009.07.008_bib10","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1158\/1055-9965.EPI-07-2659","article-title":"Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology","volume":"17","author":"Lazcano-Ponce","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.arcmed.2009.07.008_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"issue":"suppl 10","key":"10.1016\/j.arcmed.2009.07.008_bib12","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.arcmed.2009.07.008_bib14","first-page":"72","article-title":"HPV vaccination catch up program\u2014utilisation by young Australian women","volume":"38","author":"Weisberg","year":"2009","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.arcmed.2009.07.008_bib15","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2009.07.008_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2009.07.008_bib17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2009.07.008_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2009.07.008_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/03610929808832160","article-title":"Exact power and sample size for vaccine efficacy studies","volume":"27","author":"Chan","year":"1998","journal-title":"Theory Meth"},{"key":"10.1016\/j.arcmed.2009.07.008_bib20","first-page":"108","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.arcmed.2009.07.008_bib21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.23260","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women","volume":"122","author":"Perez","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2009.07.008_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2009.07.008_bib23","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.vaccine.2008.09.073","article-title":"HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine","volume":"26","author":"Joura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"suppl 11","key":"10.1016\/j.arcmed.2009.07.008_bib25","doi-asserted-by":"crossref","first-page":"L96","DOI":"10.1016\/j.vaccine.2008.05.062","article-title":"Recommendations for cervical cancer prevention in Latin America and the Caribbean","volume":"26","author":"Mu\u00f1oz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virologic evidence of HPV infection","volume":"196","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2009.07.008_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.arcmed.2009.08.004","article-title":"A cost-effectiveness analysis of a quadrivalent (HPV 6\/11\/16\/18) human papilloma virus (HPV) vaccine in Mexico","volume":"40","author":"Reynales-Shigematsu","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2009.07.008_bib28","first-page":"505","article-title":"Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico","volume":"14","author":"Salmer\u00f3n","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2009.07.008_bib29","article-title":"The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16\u201324","volume":"23","author":"Majewski","year":"2009","journal-title":"J Eur Acad Dermatol Venereol Apr"},{"key":"10.1016\/j.arcmed.2009.07.008_bib30","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2009.07.008_bib31","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.vaccine.2008.06.045","article-title":"The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination","volume":"26","author":"Chesson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2009.02.015","article-title":"The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas","volume":"74","author":"Kong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arcmed.2009.07.008_bib33","unstructured":"Giuliano A, Palefsky J. The efficacy of quadrivalent HPV (types 6\/11\/16\/18) vaccine in reducing the incidence of HPV infection and HPV-related genital disease in young men (abstract #SS20). EUROGIN, Nice, France, November 10, 2008."},{"key":"10.1016\/j.arcmed.2009.07.008_bib34","unstructured":"Palefsky J, Giuliano A. The efficacy of quadrivalent HPV (types 6\/11\/16\/18) vaccine in reducing the incidence of HPV infection in young men (please verify that abstract is same number as reference 33) (abstract #SS-20). EUROGIN, Nice, France, November 13, 2008."},{"issue":"Suppl 11","key":"10.1016\/j.arcmed.2009.07.008_bib35","doi-asserted-by":"crossref","first-page":"L73","DOI":"10.1016\/j.vaccine.2008.05.027","article-title":"Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean","volume":"26","author":"Winkler","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.vaccine.2008.12.045","article-title":"HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations","volume":"27","author":"Wong","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.02.050","article-title":"Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program","volume":"27","author":"Tozzi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.008_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-2002-39579","article-title":"HPV induced cervical carcinogenesis: molecular basis and vaccine development","volume":"124","author":"Kaufmann","year":"2002","journal-title":"Zentralbl Gynakol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:38:04Z","timestamp":1759261084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0188440909001349"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.07.008","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a Quadrivalent HPV6\/11\/16\/18 Vaccine in Mexican Women: Public Health Implications for the Region","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}